Page last updated: 2024-09-05

ro 32-3555 and ro 42-5892

ro 32-3555 has been researched along with ro 42-5892 in 2 studies

Compound Research Comparison

Studies
(ro 32-3555)
Trials
(ro 32-3555)
Recent Studies (post-2010)
(ro 32-3555)
Studies
(ro 42-5892)
Trials
(ro 42-5892)
Recent Studies (post-2010) (ro 42-5892)
151469198

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abbenante, G; Fairlie, DP; Leung, D1
Hopfgartner, G; Husser, C; Zell, M1

Reviews

1 review(s) available for ro 32-3555 and ro 42-5892

ArticleYear
Protease inhibitors: current status and future prospects.
    Journal of medicinal chemistry, 2000, Feb-10, Volume: 43, Issue:3

    Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors

2000

Other Studies

1 other study(ies) available for ro 32-3555 and ro 42-5892

ArticleYear
Rapid screening and characterization of drug metabolites using a new quadrupole-linear ion trap mass spectrometer.
    Journal of mass spectrometry : JMS, 2003, Volume: 38, Issue:2

    Topics: Animals; Benzophenones; Dogs; Humans; Imidazoles; Nitrophenols; Pharmaceutical Preparations; Rats; Spectrometry, Mass, Electrospray Ionization; Tolcapone

2003